The Oncology Institute, Inc. (NASDAQ: TOI) reported Q2 EPS of ($0.15), $0.06 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $119.8 million versus the consensus estimate of $112.56 million.

For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.